URGING THE HAWAII STATE DIRECTOR OF HEALTH TO ISSUE A STATEWIDE ORDER TO ALLOW FOR THE SALE AND PURCHASE OF NEBULIZED BUDESONIDE WITHOUT A PRESCRIPTION OR CONSULTATION WITH A HEALTHCARE PROVIDER.
Referred to HLT, CPC, referral sheet 19
Summary
The concurrent resolution asks the Hawaii State Director of Health to issue a statewide order permitting people to buy nebulized budesonide without a prescription or doctor’s consultation. It also encourages the Board of Pharmacy to set labeling and instruction rules for the product and its nebulizer devices. The measure aims to expand access to a medication the sponsors say can help treat respiratory illnesses like COVID‑19.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HCR 134 changes status, plus AI-powered summaries and stage predictions.
Sign up free